𝔖 Bobbio Scriptorium

✦ LIBER ✦

What the human genome project will not tell us: the role of micro-organisms in disease

✍ Scribed by Azra Raza

Book ID: 114118930
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 43 KB
Volume: 25
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(00)00110-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Role of the Human Genome Project in

The Role of the Human Genome Project in Disease Prevention

✍ M.M. Gottesman; F.S. Collins 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Type 2B von Willebrand disease and relat

Type 2B von Willebrand disease and related disorders of patients with increased ristocetin-induced platelet aggregation: what they tell us about the role of von Willebrand factor in hemostasis

✍ H. J. Weiss 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Role of PCR in the diagnosis and managem

Role of PCR in the diagnosis and management of CMV in solid organ recipients: What is the predictive value for development of disease and should PCR be used to guide antiviral therapy?

✍ M.M. Abecassis; A.J. Koffron; M. Buckingham; D.B. Kaufman; J.P. Fryer; J. Stuart 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Dr. Charles Rice**Presented by J. T. Llo

Dr. Charles Rice**Presented by J. T. Lloyd, Section on Historical Pharmacy, A. Ph. A., Dallas meeting, 1936, who stated as follows:To account for the origin of this paper, I will explain that it is the stenographic record of a statement made by my father, about fifteen years ago, in response to my request that he tell me what he knew concerning Dr. Charles Rice. When the notes were transcribed I submitted the paper to my father for approval or correction. He made little if any change, but requested me not to make use of it during his lifetime. This paper I am now presenting.– J. T. Lloyd.

✍ Lloyd, John Uri 📂 Article 📅 1936 🏛 Elsevier ⚖ 234 KB 👁 2 views

Renal insufficiency and anemia are indep

Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction1,21As published material, the contents of this manuscript may not be cited, quoted, reproduced or published without the consent of the authors.2The analyses upon which this publication is based were performed under Contract Number 500-96-P704, entitled âOperation Utilization and Quality Control Peer Review Organization (PRO) for the State of Georgiaâ and sponsored by the Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services. The conclusions and opinions expressed, and methods used herein are those of the authors. They do not necessarily reflect CMS policy. The authors assume full responsibility for the accuracy and completeness of the ideas presented. This article is a direct result of the Health Care Quality Improvement Program initiated by CMS, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of this Contractor. Ideas and contributions to the authors concerning experience in engaging with issues presented are welcomed.

✍ Langston, Robert D.; Presley, Rodney; Flanders, W. Dana; Mcclellan, William M. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 373 KB